Skinbiotherapeutics Share Discussion Threads

[incanus] 05/6/2018 15:18

Sold remainder today. Buy back at or around current levels, possibly 13/14p. I want over exposure in Opti through summer. I have a free risk carry. No brainer.

[bobalot] 05/6/2018 10:41

There will be many more news releases as we approach Q3 imo.

[bobalot] 05/6/2018 10:39

Exactly...the carriers are generic and used to demonstrate the functionality of the patented ingredients. The ingredients work in a cream and so they will likely work just as effectively in other carriers.

And that is why recent testing was so important to pass...a real moment to celebrate.

The next hurdle is stability testing by an independent lab...no doubt SBTX have done their own stability testing at Manchester Uni...but that research has to be formalised with an independent test lab to get regulatory certification. And that will happen before the Q3 Human Trials.

[onedayrodders] 05/6/2018 10:31

When I spoke to Cath at recent UK Investor show she confirmed there is now no rush for gel or lotions now that they have proved the science works in the cream formulation.

[bobalot] 05/6/2018 10:30

ODR Predicting again...all of your predictions over the last three weeks have been wrong --- perhaps its time to stop predicting price action and just go with the share price flow.

[bobalot] 05/6/2018 10:27

The Final Test Hurdle -- Stability Testing.

Before human Testing can start in Q3 the cosmetic cream or gel or lotion must undergo and pass Stability Testing which tests the functionality and shelf life of the generic carrier cream patented ingredients. The business is confident its patents will pass the stability testing phase allowing Human Testing by an independent lab in Edinburgh to do field trials on 120 people.

[onedayrodders] 05/6/2018 10:25

Volume has dried up which usually means weakness will return as most AIM investors think 2 days is long term.

14/15p a possibility short term due to that impatience.

just IMHO

[bobalot] 04/6/2018 08:35

Good start today, buying has resumed at 16.25p, likely that a bounce is in the offering imo. The fib oscillator was telling fibs --- proved wrong a second time in two weeks...lol

[elrico] 03/6/2018 18:42

ODR - It wasn't intended as advice, more like predictive indicator is often use. :)

[onedayrodders] 03/6/2018 10:33

yep and some took his advice

;o)

[slartybartfaster] 03/6/2018 00:16

elrico made the point earlier.

[bobalot] 02/6/2018 17:05

This stock offers investors excellent trading opportunities....imo.

[onedayrodders] 01/6/2018 17:54

Yes indeed elrico

[bobalot] 01/6/2018 16:17

The stock is very popular and news will keep flowing imo....SBTX has developed a very long pipeline and has a waiting major corporate customer who is getting ready for the Cosmetic creams, gels and lotion approval -- which looks like a certainty.

Therefore free cash flow is highly likely to be achieved sooner than expected instead of the long wait of years and drip fed expectations that many Aim businesses exhibit.

[dire cons] 01/6/2018 16:05

Looks as though this has spiked, no news soon and it will collapse.
GOOD LUCK EVERYONE.

[bobalot] 01/6/2018 15:09

THERE ARE GOING TO BE A NUMBER OF NEWS RELEASES as we near the human trials; e.g. Patent awards in the USA and China and perhaps more MTA agreements from some of the several corporates who have shown a lot of interest in the technology using lysates extracted from microbes.

SO THERE IS A LOT GOING ON BEHIND THE SCENES imo.

[elrico] 01/6/2018 15:02

ODR - Fib I mentioned is playing out perfectly again. I think we have been witnessing OPTI PI's trading SBTX because it's essentially limited risk. By that I mean they are less concerned by any spike being missed because they have a free carry via their OPTI holding. It may calmed down nearer the humane trials release, but for now, it's going to be traded.

[onedayrodders] 30/5/2018 11:05

Double top not good short term. I reckon without news it's another test of 14p.

[bobalot] 30/5/2018 10:03

SkinBioTherapeutics
‏

@SkinBioT

SkinBioTherapeutics to present on 20 June 2018 at the Shares and AJ Bell Spotlight Evening in London. Shareholders and potential investors can register now for free at: @SHARESmag #SBTX

[bobalot] 29/5/2018 09:23

SkinBioTherapeutics shares in UK government grant with Manchester University

29 May 2018 | 09:12am
StockMarketWire.com - SkinBioTherapeutics said it had been selected as an industrial partner in a grant awarded by the the UK government's Biotechnology and Biological Sciences Research Council to the University of Manchester.

The grant of around £600k provided the university with funding for up to three years to investigate how ageing affects the skin and in particular, its microbiome.


At 9:12am: [LON:SBTX] SkinBioTherapeutics Plc share price was 0p at 17p

Story provided by StockMarketWire.com,

[bobalot] 29/5/2018 08:51

SkinBio gets first call on any IP/Patents generated...i.e. more products in the pipeline, this time for anti-aging --- another huge market.